Stem Cells and the Future of Regenerative Medicine (2002) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Agenda and Speaker Biographies
Appendix B: Workshop Agenda and Speaker Biographies
Pages 79-88
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 79... ...
APPENDIX B Workshop Agenda and Speaker Biographies Stem Cells and the Future of Regenerative Medicine June 22, 2001 National Academy of Sciences Building Washington, D.C. OVERVIEW TALKS 8:30-9:30 am Agenda Bert Vogelstein Johns Hopkins University Irving Weissman Stanford University School of Medicine Opening Remarks Overview of Stem Cell Biology James Thomson University of Wisconsin- Human Embryonic Madison Stem Cells STEM CELLS IN DIFFERENT ORGAN SYSTEMS SESSION ~ 9:30-10:45am Ernest Beutler Bone Marrow The Scripps Research Transplantation Institute Margaret GoodeB Texas Medical Center Markus Grompe Oregon Health Sciences University Stem Cells from Muscle and Bone Gene Therapy in the Liver 79
|
From page 80... ...
2:45-4:30pm LeRoy Walters Georgetown University Kennedy Institute of Ethics Fetal Liver Stem Cells Producing Stem Cells Stem Cells in the Retina Repairing the Damaged Brain Transplantation of Neural Stem Cells in Humans Biotech Industry and Public Funding Implications of Restrictions on Stem Cell Research FDA Perspectives on the Challenges of Stem Cell Therapies Perspectives on Stem Cell Research form Other Countries 80
|
From page 81... ...
Appendix B Kevin FitzGerald Georgetown University Medical Center Arguments Against the Use of Human Embryonic Stem Cells David Prentice Alternatives to Human Indiana State University Embryonic Stem Cells George Annas Boston University School of Public Health 4:30-5:00pm 5:00pm Bert Vogelstein Summary and Discussion ADJOURN Arguments in Favor of the Use of Excess Human Embryos Audio files from the workshop are available until December 31, 2002, on the Web at http://www.nationalacademies.org/stemcells.
|
From page 82... ...
He is the author or editor of a dozen books on health law and ethics, including The Rights of Patients, fudging Medicine, American Health Law, Standard of Care, Some Choice, and Health and Human Rights. He has held a variety of regulatory positions including chair of the Massachusetts Health Facilities Appeals Board, vice-chair of the Massachusetts Board of Registration in Medicine, and chair of the Massachusetts Organ Transplant Task Force.
|
From page 83... ...
He also serves as a consultant to the Juvenile Diabetes Research Foundation, the United States Catholic Conference, and as a member of the American Association for the Advancement of Science Program of Dialogue on Science, Ethics, and Religion. He is a founding member of Do No Harm: Coalition of Americans for Research Ethics, an organization dedicated to the promotion of scientific research and health care that does no harm to human life.
|
From page 84... ...
His research analyzes hemopoietic differentiation using retroviruses as markers and has focused on gaining insight into the in viva clonal behavior of the most primitive fetal liver or adult bone marrow hematopoietic stem cells. In particular, his laboratory is interested in understanding the mechanistic aspects of: (1)
|
From page 85... ...
Prentice, PhD, is professor of life sciences at Indiana State University, adjunct professor of Medical and Molecular Genetics for Indiana University School of Medicine, and a founding member of Do No Harm: The Coalition of Americans for Research Ethics, an organization dedicated to the promotion of scientific research and health care that does no harm to human life. One current focus of his research is on adult stem cells and their differentiation signals.
|
From page 86... ...
Siegel has served as founding director of the Division of Clinical Trial Design and Analysis, deputy director of the Division of Cytokine Biology, chief of the Laboratory of Cellular Immunology, and senior investigator in the Division of Virology. He trained in medicine and infectious diseases at Stanford University School of Medicine, in internal medicine at the University of California, San Francisco, and in biological sciences at the California Institute of Technology.
|
From page 87... ...
His laboratory has identified and isolated the blood-forming stem cell from mice and has defined, by lineage analysis, the stages of development between the stem cells and mature progeny. In addition, the Weissman laboratory has pioneered the study of the genes and proteins involved in cell adhesion events required for lymphocyte homing to lymphoid organs in viva, either as a normal function or as events involved in malignant leukemic metastases.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.